Scientists at a lab in Montana have had promising results with an Ebola vaccine, and other U.S. researchers plan to begin clinical trials this fall.
Several different vaccines to protect people from the deadly virus are under development in the U.S.
The Ebola virus vaccine developing at the Rocky Mountain Laboratories in Hamilton, Montana has done well when tested on monkeys. It has yet to be tested on humans. It’s based on a livestock pathogen.
At the lab, scientists with the National Institute of Allergy and Infectious Diseases put viruses under the microscope and plot ways to attack them and save lives in the process.
At this time, progress in the fight against Ebola has been lacking. According to experts at the Rocky Mountain lab, however, releasing a drug prematurely would not have lasting benefits on those infected with the disease.
CCTV America’s Hendrik Sybrandy reports.
Follow Hendrik Sybrandy on Twitter @hsybrandy